Omnichannel

"Too much is never enough." "All things in moderation.” There’s a big gap between those two axioms. And for field forces in life sciences, that gap often creates a big debate: How much data is too much? Your reps want to be informed. They want to know the latest insights when they’re out detailing doctors. Next best action suggestions help. But… if you give them too much information (and change ...

In the life sciences industry, traditional measurement tactics are falling short. They cannot address the complexities of the modern customer journey. The surge of digital channels and evolving customer behaviors are driving this difficulty. So how do you respond? This white paper redefines how life sciences companies approach omnichannel measurement. Authored by industry leaders Vandana Singh ...

Data drives everything we do today. At first glance, more data seems like a good thing. The more insight you have into something, the better the decisions you can craft. But that isn’t always the case. Too much information has proven overwhelming for many organizations, especially pharma companies. The rise of omnichannel marketing, where multiple avenues of reaching a consumer have been ...

As the life sciences industry becomes more data-driven, companies are harnessing advanced analytics to personalize interactions with healthcare professionals, patients, and stakeholders across multiple channels. In this scenario, identifying the best algorithm for omnichannel and the next best action (NBA) recommendations is crucial for optimizing customer engagement and achieving intended ...

The nature of sales operations in life sciences is changing rapidly as digital marketing becomes a core function for marketers. Sales representatives are still central to pharma sales, but they need to leverage data and analytics to tailor conversations and provide a personalized customer experience while helping healthcare professionals solve problems in a complex healthcare environment. Axtria ...

The link between life sciences field teams and the healthcare community has been vital in delivering valuable drug information that supports informed decision-making by the physician. Most of the tools of the trade for omnichannel orchestration, such as triggered communications, A/B testing, and Customer Data Platforms, were initially developed for digital marketing. Field teams work differently ...

The transition from multichannel to omnichannel customer engagement is critical for the industry but not as straightforward as it may seem. Over the years, pharmaceutical companies have tried to make a move, but very few can claim to be successful and having achieved omnichannel maturity. COVID-19 accelerated the digitization drive across industries and demonstrated the potential of virtual ...

The Covid-19 pandemic has forced pharma companies to rethink their sales and marketing strategies and adapt to a virtual setup. Now that the pandemic is easing out, companies are recalibrating their business processes proactively to remove excess operational costs, data silos, and other growth hindrances. The newly adopted omnichannel world has given companies access to interactive tools and ...

From broadcasting a series of monologues at ‘easy’ customers in order to sell products, to having an engaging and effective dialogue with fairly ‘complex’ targets to make meaningful connections – marketing has definitely come a long way. The touch point with the customer no longer ends when the store closes. The ‘purchase model’ has become very complex. The reality is it’s no longer about a ...